前一天，国家金融监督管理总局上海监管局开出"罚单"，交通银行上海市分行因多项违规被罚没款合计 611.86951万元。其违法违规事实包括向关系人发放信用贷款、违规对个别贷款品种部分免息、置换类 个人经营贷款管理严重违反审慎经营规则等多项内容。同时，上海金山支行副行长富宇等8名相关责任 人分别被警告或警告并罚款。 据不完全统计，2026年开年以来，交通银行各地分支行已收到至少5张罚单。1月5日，交通银行太仓分 行同样因流动资金贷款"三查"不到位，被罚款35万元，时任副行长高晓静被警告并处罚款7万元;1月6 日，交通银行陕西省分行也因发放固定资产贷款不审慎等问题，被陕西监管局罚款253万元，多名责任 人受到警告等处罚;1月9日，交通银行重庆璧山支行因贷款"三查"不到位、信贷资金被挪用，被罚款30 万元，时任行长助理、副行长谭欣被警告。 而此前的2025年年底，交通银行还曾收到中国人民银行开出的总额6700余万元的"天价罚单"，涉及账户 管理、反洗钱、财政资金管理等众多核心领域。 一系列分支行被罚背后，折射出交通银行在合规管理中存在系统性薄弱问题环节。有业内人士认为，近 年来的监管政策强烈释放出严监管常态化、精准化 ...

2025年，国网渭南供电公司将合规管理融入电网建设、电力保供、经营管理等各项工作，着力提升合规 管理水平。一是坚持党建引领，建立"党委领导、法务统筹、部门协同、全员参与"的责任体系，全年共 组织领导班子成员开展专题学法活动12次，开展干部任前法治谈心谈话194人次。二是依托线上管理平 台，建立"业务部门初审+法务部门复审"的合同双审核管理机制，努力从源头防范法律风险，全年共审 核合同2286份。三是组织开展覆盖全体员工的合规文化宣传活动，培养企业合规师41名，使合规理念更 加深入人心。 屈大利 （来源：法治日报） 转自：法治日报 ...

近年来，周村农商银行围绕"合规文化、案件防控、员工行为"三个维度，开展合规管理工作，引导员工 明规矩、知敬畏、存戒惧，守牢合规底线，筑牢业务高质量发展的安全"堤坝"。 抓实文化合规，推进合规文化建设。一是打造合规氛围体系。制定年度合规文化建设计划、普法工作计 划、合规活动实施方案等文件，建立工作配档表，明确内容、时限、频次、方式、对象、责任主体等方 面，构建顶层规划；二是塑造日常合规文化。定期开展高管基层宣讲、合规宣誓、线上合规答题、合规 培训、合规宣辅等活动，引导全员深化合规认知，强化合规操作，推动合规理念入脑入心，巩固业务发 展的合规根基；三是强化案例警示教育。将案例警示教育作为月度经营分析固定内容，并督促各条线再 次深入学习交流，做到层层覆盖、全员参与，引导员工以案为鉴、主动甄别、抵制违规，守牢合规底 线。 抓实案防合规，构建防控协同体系。一是完善案防工作架构。制定案防排查方案，细化工作要点、排查 方法及责任分工，对案排查发现的问题，建立处置台账，明确责任人和整改时限，实行整改跟踪管理， 提升整改成效；二是夯实案防履职能力。制定案防工作履职清单，规范各条线职责范围，持续做好制度 机制建设、案件风险排查、 ...

Core Viewpoint - Tianjin Pharmaceutical Industry Co., Ltd. (SH600488) faces regulatory scrutiny due to non-compliance in contract management and insufficient risk identification in R&D projects, leading to a significant decline in profits and operational challenges [1][2]. Group 1: Regulatory Issues - The company received an administrative regulatory decision from the Tianjin Securities Regulatory Bureau, mandating corrections due to non-standard contract management and inadequate risk identification in R&D projects [1]. - Five current and former executives received warning letters, indicating serious compliance issues within the company's governance structure [2]. Group 2: Financial Performance - For the first three quarters of 2025, the company reported a revenue of 2.232 billion yuan, a year-on-year decrease of 13.24%, and a net profit attributable to shareholders of 69.54 million yuan, down 62.75% [4]. - The company incurred a non-recurring loss of 66.17 million yuan, with antitrust penalties amounting to 69.19 million yuan, further straining profitability [2][4]. Group 3: Operational Challenges - The company's cash flow from operating activities was only 33.39 million yuan, a dramatic decline of 92.65% year-on-year, primarily due to extended payment cycles and increased market competition [4]. - The ongoing pressures from centralized procurement and stringent regulations necessitate a balance between compliance investments and R&D innovation, as the company faces compounded performance and compliance risks [4].

Core Viewpoint - The leading baby care brand, Daikosi, is under investigation for alleged false advertising related to its children's lip balm, which claimed to be "food grade," violating regulations on children's cosmetics [1][5]. Group 1: Regulatory Violations - The investigation centers on Daikosi's children's lip balm, which prominently advertised "food grade" and "safe if licked" on an e-commerce platform, misleading consumers [2][7]. - The National Medical Products Administration has clarified that cosmetics and food are governed by different regulations, and there is no such thing as "food grade" cosmetics [2][7]. - According to the Children's Cosmetics Supervision and Administration Regulations, labels on children's cosmetics must not include terms like "food grade" or "edible" [2][7]. Group 2: Compliance Issues - This is not the first compliance crisis for Daikosi; the company was fined 5,000 yuan for false advertising in December 2025 for claiming certain products were suitable for pregnant women without evidence [3][8]. - Since its establishment in 2017, Daikosi has faced at least five administrative penalties for various violations, including false claims about product efficacy and suitability [3][8]. - Despite being a leading brand with nearly 1.5 billion yuan in annual sales and significant backing from industry players, Daikosi has repeatedly failed in compliance management [3][8]. Group 3: Industry Implications - Daikosi issued an apology on January 22, stating that the misleading claims were due to a misunderstanding by promotional staff and have since been retracted [4][9]. - The product in question, which previously ranked high in sales, has had its "food grade" claims removed from e-commerce platforms, with over 300,000 units sold [4][9]. - This incident highlights ongoing compliance issues within the baby skincare industry, where some brands prioritize marketing over regulatory adherence, prompting a shift towards compliance-focused competition in the future [4][9].

Core Viewpoint - The rise of digital consumption has led to the proliferation of organized and chain-like illegal activities in the black and gray industry, posing threats to market order and consumer safety [1] Group 1: Company Initiatives - The company adheres to a "zero tolerance" principle against black and gray market activities, focusing on user rights protection and platform security governance [1] - The company is enhancing its e-commerce platform governance by leveraging supply chain, AI, and digital technology capabilities [2] - The company has established a dynamic closed-loop management system for data security, involving internal teams and external third-party assessments [2] Group 2: Collaboration with Law Enforcement - The company actively collaborates with law enforcement to combat black and gray market activities, providing critical case investigation leads [3] - Recent examples include the identification of fraudulent activities related to impersonating customer service and sending recovery messages, with evidence collected and shared with police [3] - The company emphasizes that combating black and gray market activities is a long-term systematic project, maintaining a compliance-first approach [3] Group 3: Consumer Awareness - The company advises consumers to enhance their security awareness and be cautious of inducements related to "cash recovery" and "operational order monetization" [4] - Consumers are encouraged to verify unusual situations through official channels and retain evidence for potential legal action [4] - The company commits to supporting customers in reporting incidents and collaborating with law enforcement to ensure customer fund safety [4]

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：001376 证券简称：百通能源 公告编号：2026-005 江西百通能源股份有限公司 关于召开2026年第一次临时股东会通知公告 本公司及董事会全体成员保证信息披露内容的真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 江西百通能源股份有限公司（以下简称"公司"）于2026年1月27日召开第四届董事会第十二次会议，决 定于2026年2月12日召开公司2026年第一次临时股东会，现将本次会议的有关事项通知如下： 一、召开会议的基本情况 1、会议届次：2026年第一次临时股东会 2、会议召集人：公司董事会 经公司第四届董事会第十二次会议审议通过《关于提请召开2026年第一次临时股东会的议案》。 3、会议召开的合法、合规性：本次股东会会议的召开符合有关法律、行政法规、部门规章、规范性文 件、业务规则和《江西百通能源股份有限公司章程》等规定。 4、会议召开时间： （1）现场会议时间：2026年2月12日（星期四）13:30； （2）网络投票时间：2026年2月12日；其中通过深圳证券交易所交易系统进行网络投票的具体时间为： 2026年2月12日9: ...

Core Insights - In 2025, financial regulatory authorities issued a total of 2,588 fines to banking institutions, amounting to 2.641 billion yuan, marking a significant increase from 2024 [1][2] - The regulatory approach has shifted from punishing institutions to holding individual employees accountable, with over 3,000 banking personnel penalized [1][9] - The trend of "strict regulation, strong accountability, and zero tolerance" has become normalized, focusing on quality and effectiveness rather than broad coverage [1][2] Regulatory Trends - The number of large fines (over 1 million yuan) issued to banking institutions increased significantly, with 455 such fines in 2025, including 31 fines exceeding 10 million yuan [2][3] - The majority of penalties were concentrated in the second half of 2025, with a notable spike in fines towards the end of the year [3][4] - The largest single fine in 2025 reached 97.9 million yuan, attributed to poor management practices across various banking operations [3] Types of Violations - Major areas of violations included credit business, anti-money laundering, and internal control systems, with nearly half of the large fines related to credit business infractions [6][8] - Internet loan business violations emerged as a significant concern, with several banks penalized for inadequate risk management during rapid business expansion [7][8] - Anti-money laundering fines surged to 1,381 in 2025, a 185.92% increase from 2024, reflecting heightened regulatory scrutiny [8] Individual Accountability - The "double penalty" system has led to a substantial increase in fines against individual banking personnel, with 3,933 personal fines issued in 2025 [9][10] - Over 100 banking employees received lifetime bans from the industry, a notable rise compared to previous years [10][11] - The regulatory focus on individual accountability aims to enhance compliance awareness and risk management within financial institutions [11] Future Outlook - The trend of stringent regulation and risk prevention is expected to continue into 2026, with a shift towards behavior-based assessments rather than merely financial metrics [12] - Compliance capabilities are anticipated to become essential for the survival of banks, with a focus on proactive governance and integration into business processes [12] - Regulatory attention will likely center on corporate governance, data security, consumer rights protection, and compliance with green and inclusive finance policies [12]

Core Viewpoint - Yibai Pharmaceutical is facing significant survival challenges, with a projected net profit loss of 285 million to 342 million yuan for 2025, marking the second consecutive year of substantial losses due to production violations and compliance issues [1][2] Group 1: Financial Performance - The company expects a net profit loss attributable to shareholders of 285 million to 342 million yuan for 2025, with a similar loss of 317 million yuan in 2024, indicating no improvement [2] - Revenue is projected to decline by 14% in the reporting period, while costs are expected to decrease by 18%, yet costs will still exceed revenue, leading to losses [6] - Sales expenses from 2022 to 2024 were excessively high, reaching 1.196 billion, 1.238 billion, and 1.097 billion yuan, accounting for 43% to 50% of revenue, while R&D expenses were only 127 million, 112 million, and 101 million yuan [5] Group 2: Product Issues - The core product, Aidi Injection, has been suspended due to production violations, including improper processing and inaccurate record-keeping, leading to significant revenue loss [2][3] - Aidi Injection generated revenues of 737 million, 693 million, 480 million, and 473 million yuan from 2020 to 2023, constituting 21.61%, 20.71%, 17.57%, and 16.77% of total revenue, respectively [3] - The company also faced issues with its pediatric cough syrup, which was halted due to non-compliance in production record-keeping, further exposing its compliance weaknesses [3] Group 3: Compliance and Management - Yibai Pharmaceutical has stated that it adheres to GMP standards and has established a drug safety committee to oversee production processes and compliance [4] - The company has been under scrutiny from regulatory bodies due to its high sales expenses, with the Shanghai Stock Exchange issuing inquiries regarding the legitimacy and compliance of these expenses [5] Group 4: Strategic Response - To address its challenges, Yibai Pharmaceutical plans to implement a "one ship, two wings" development strategy, focusing on its pharmaceutical core business while expanding into healthcare services and wellness sectors [7] - The company aims to optimize marketing resource allocation, explore potential in dormant products, and enhance operational efficiency through supply chain optimization and digital improvements [7]

银行人事了解到，兴业银行七家一级分行合规官已定，均由分行行长兼任。 北京分行行长郝超，兼任北京分行合规官；历任兴业银行济南分行副行长，长春分行行长，石家庄分行 行长，南京分行行长，2022年任北京分行行长。 来源：金融人事mini 自2025年12月以来，国内银行配备首席合规官职位明显提速，多由现有高管兼任。 股份行中，兴业银行首席合规官由副行长孙雄鹏兼任；民生银行的由副行长黄红日兼任；平安银行的由 行长助理、首席风险官吴雷鸣兼任。 这一系列动作的背后，源于监管政策指导。2025年3月《金融机构合规管理办法》正式施行，过渡期为 一年，目前已接近尾声。办法明确要求金融机构应在总部设立首席合规官，原则上应在省级分支机构或 者一级分支机构设立合规官，可根据自身经营情况单独设立，也可由高管兼任。 其中，由金融机构行长兼任首席合规官，以及由金融机构省级分支机构或者一级分支机构行长兼任合规 官的，不需要另行取得任职资格许可。比如，南京银行、江苏银行、江阴银行的首席合规官均由行长兼 任。 上海分行行长柯楷，兼任上海分行合规官；曾任兴业银行企业金融业务管理部总经理、人力资源部总经 理，2024年5月任上海分行行长。 南京分行 ...